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ABSTRACT
Introduction: The prevalence of acute bacterial
skin and skin structure infections (ABSSSIs)
continues to increase. Bloodstream infection
(BSI) is a severe secondary complication of
ABSSSI. The objective of this study was to
determine clinical and sociodemographic risk
factors for BSI in patients with acute bacterial
skin and skin structure infections (ABSSSIs) and
to determine if sociodemographic factors
impact severity at presentation.
Methods: This was a retrospective unmatched
(1:1) case-control study. Predictors of BSI and
severe infection were sought through multi-
variable logistic regression analyses. Cases and
controls were collected from two major medical
centers located in downtown Detroit, Michigan:
the Detroit Medical Center and the Henry Ford
Health System. The population of interest
included adult patients with community-onset
(CO) ABSSSI treated at a participating hospital
between January 2010 and December 2015.
Cases were defined as those developing BSI
within 48 h of admission with CO-ABSSSI as the
primary source, while controls were those with
CO-ABSSSI without BSI.
Results: A total of 392 patients (196 cases, 196
controls) were included. Independent predic-
tors of BSI were male gender (aOR 1.85: 95% CI
1.11, 3.66), acute renal failure (aOR 2.08: 95%
CI 1.18, 3.66), intravenous drug use (aOR 4.38,
95% CI 2.22, 8.62), and prior hospitalization
(aOR 2.41, 95% CI 1.24, 4.93). African American
race (aOR 2.18, 95% CI 1.38, 3.4), leukocytosis
(aOR 2.24, 95% CI 1.41, 3.55), and prior hos-
pitalization (aOR 2.07, 95% CI 1.19, 3.00) were
significantly associated with infection severity.
Conclusion: Both clinical and sociodemo-
graphic factors were associated with BSI and
severe infection underscoring the importance of
social determinants of health in outcomes
among underserved populations.
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INTRODUCTION
Acute bacterial skin and skin structure infec-
tions (ABSSSIs) are complicated skin and skin
structure infections that generally require hos-
pitalization and parenteral antibiotics and
include the diagnosis of cellulitis/erysipelas,
wound infection, major cutaneous abscess with
an accompanying redness, or edema that
extends to a minimum lesion surface area of
75 cm [2, 1]. ABSSSIs are among the most
common infections encountered in community
and healthcare settings [2, 3]. The number of
patients diagnosed with ABSSSIs has steadily
increased in the USA over the last 2 decades
[4–6]. This increase in ABSSSIs has coincided
with rising hospital admissions and complica-
tions including secondary bone and joint
infections, amputations, and bloodstream
infections (BSI) [7, 8]. BSI, although still rela-
tively rare (5–12%) [9, 10], is considered one of
the most severe complications of ABSSSI as it
carries a significant risk for morbidity and
mortality [9, 11]. The most common bacterial
pathogen associated with BSI secondary to
ABSSSI is Staphylococcus aureus. Although once
restricted to patients with traditional health-
care-associated risk factors, community-associ-
ated methicillin-resistant S. aureus (CA-MRSA) is
now a predominant pathogen in ABSSSI, and
prevalence is typically higher in urban popula-
tions, disproportionately affecting individuals
of low socioeconomic status [12, 13].
Because secondary BSI in ABSSSI is associated
with high rates of mortality, several investiga-
tors have attempted to identify patient charac-
teristics that are associated with this
complication [9, 14, 15]. However, risk factors
for BSI have not been evaluated in African
American patients with ABSSSI and low socioe-
conomic status in an urban setting. Therefore,
the primary aim of this study was to identify
significant clinical and sociodemographic risk
factors for BSI in patients with community-on-
set (CO) ABSSSI residing in downtown Detroit.
In addition, we sought to determine the extent
to which clinical and sociodemographic factors
impact severity of infection in patients with
ABSSSI ? BSI.
METHODS
Study Setting and Patient Population
This retrospective, case-control study was con-
ducted at two major medical centers located in
downtown Detroit, Michigan: the Detroit
Medical Center (DMC) and the Henry Ford
Health System (HFHS). Both medical centers
have centrally located campuses and therefore
service a large section of the inner-city Detroit
patient population. The population of interest
consisted of patients hospitalized with CO-
ABSSSI diagnosed within 48 h of admission, as
previously defined [16] between January 2010
and December 2015. Patients were excluded if
they had any of the following concomitant
diagnoses because these infections tend to have
a higher likelihood of poor patient outcomes
irrespective of concomitant BSI: [17]
osteomyelitis, septic arthritis, prosthetic device-
related infection, an animal or human bite,
burn, necrotizing fasciitis, pyomyositis, or
ABSSSI secondary to recent (within 2 weeks)
surgery. Cases were defined as inpatients with at
least one positive blood culture meeting the
Center for Disease Control and Prevention
(CDC) BSI criteria [18] collected within 48 h of
admission and in whom ABSSSI was docu-
mented as the primary source. Study controls
consisted of inpatients with CO-ABSSSI and
blood cultures collected within 48 h of admis-
sion demonstrating no microbiologic evidence
of BSI.
Data Collection and Definitions of Study
Variables
Both case and control patients were identified
using International Classification of Diseases,
Ninth Revision, Clinical Modification [ICD-9-
CM] diagnostic codes via the DMC and HFHS
electronic medical records (EMRs). Data
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elements including demographics, comorbid
conditions, prior hospitalization (180 days),
history of S. aureus infection (60 days), prior
ABSSSI (60 days), recent antibiotic exposure
(30 days), vital signs (using the worst physio-
logic values within 24 h of admission), labora-
tory values, microbiology and antibiotic
treatment were extracted from the EMR. All
cases were screened and entered in the secure
database, REDCap (Research Electronic Data
Capture) [19], an electronic data capture tool
hosted by Wayne State University by a trained
research assistant. Relevant data in the EMR
were used to determine whether the patient met
the criteria for ABSSSI according to FDA
definitions.
Income and education levels were derived
from the Census Bureau of Statistics by the
patient’s zip code. Severe ABSSSI was defined as
need for incision and drainage or wound
debridement in the operating room, amputa-
tion, admission to the intensive care unit (ICU)
or severe sepsis, as previously defined [20].
Complications secondary to ABSSSI infection
were defined as the development of endocardi-
tis, osteomyelitis, and/or other sites of meta-
static infection not present on admission.
Thirty-day post-discharge vital status was
ascertained from in- and outpatient records and
categorized as deceased or alive with or without
readmission. Patients with no follow-up visits or
readmissions within 30 days of discharge were
assumed to be alive without readmission.
Readmission was considered ABSSSI-related
based on physician documentation. This study
was approved by the institutional review boards
(IRBs) at Walden University (IRB# 0303767) and
Wayne State University (IRB# 010616M1E),
with the latter serving as coordinating IRB for
the DMC review committee and HFHS IRB. A
waiver of informed consent was granted. The
study was performed in accordance with the
1964 Helskinki Declaration and its later
amendments.
Statistical Analysis
The a priori minimum sample size for this
unmatched 1:1 case-control study was
calculated using the statistical test for differ-
ences in proportions [21]. A sample size of 187
case and 187 control subjects was required to
achieve 80% power at a 0.05 significance level
to detect an adjusted odds ratio (aOR) of C 2 for
a risk factor with a known prevalence of 10–20%
(diabetes, renal failure, prior antibiotics, recur-
rent infection) [17, 22–24].
Descriptive statistics were used to character-
ize cases and controls. Continuous variables
were compared by Student’s t test if normally
distributed and Mann-Whitney U test if the
normality assumption was not met. Categorical
variables were evaluated using Pearson’s chi-
square test or a two-tailed Fisher’s exact test, as
appropriate. Explanatory variables that were
associated with case status (P B 0.1) in the
unadjusted analyses were included in a multi-
variable logistic regression model. A backwards-
stepwise elimination approach was used to
eliminate the variable with the largest P value at
each step. The Hosmer-Lemeshow statistic was
used to evaluate the predicted and observed
probability to test for evidence of a lack of a
model fit [25]. Relationships between the
explanatory variables and BSI were evaluated
using the odds ratio (OR) and corresponding
95% confidence interval (CI). An identical pro-
cedure was used to identify a set of risk factors
independently associated with increased risk of
severe ABSSSI. All calculations were performed
using IBM SPSS Statistics software, version 22.0
(IBM SPSS, Armonk, NY).
RESULTS
A total of 5267 patient records were screened for
inclusion during the study period and 392 met
criteria for inclusion (196 cases and 196 con-
trols). Among potential cases (n = 3868), rea-
sons for exclusion included the primary BSI
source other than skin/soft tissue (n = 1579),
excluded skin infection (chronic ulcer, burn,
deep abscess, gangrene, necrotizing fasciitis;
n = 1102), hemodialysis (n = 367), prosthetic
material (n = 210), immunosuppression
(n = 120), BSI[ 48 h after admission (n = 249),
and pregnancy (n = 45). Among potential con-
trols (n = 1399), reasons for exclusion included
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concomitant infection (n = 288), excluded skin
infection (n = 610), hemodialysis (n = 158),
prosthetic material (n = 82), immunosuppres-
sion (n = 55), and pregnancy (n = 10). Demo-
graphics, sociodemographics, clinical
characteristics and outcomes of cases and con-
trols are shown in Table 1. The mean age of the
overall population was 48.7 (SD 17.4) years with
a male predominance (59.2%). With respect to
race, African Americans made up the majority
of the study population at 56.1% followed by
Caucasians at 37.2%. In terms of sociodemo-
graphic characteristics by zip code, 6.9% had
resided in a zip code with[ 30% less than a
high school education, 35.7% were considered
below the federal poverty level in terms of
median household income, and 19.1% had no
medical insurance.
On univariate analysis, cases (ABSSSI ? BSI)
were significantly older (P\0.001) and pre-
dominately male (P = 0.008) compared with
controls. No significant differences were
observed regarding race or sociodemographic
characteristics by zip code such as education,
median income levels, or the type or presence of
medical insurance (Table 1). As indicated by the
median Charlson Comorbidity Index, case
patients tended to have more underlying
comorbid conditions such as chronic renal
failure and diabetes compared with controls
(P\0.001). The most common underlying
conditions were diabetes, hypertension, and
intravenous drug use. In addition, there were
significantly more cases with previous hospi-
talization (P\0.001) and prior infection with
methicillin-susceptible S. aureus (MSSA)
(P = 0.014). Case patients also had a higher
percentage of abnormal temperature, elevated
white blood cell count (WBC), and acute renal
failure on admission (P\ 0.001). In addition,
cellulitis and infected wounds or ulcers were
more common among cases whereas controls
had a higher percentage of abscess or abscess
plus cellulitis (P\0.001). Although there was
no difference in the infection site (e.g., upper
versus lower extremity, P = 0.930), controls had
a higher rate of MRSA (P = 0.004) (Table 1).
Vancomycin was the most commonly used
antibiotic overall. As shown in Fig. 1, a signifi-
cantly higher percentage of patients with
ABSSSI ? BSI were treated with vancomycin
compared with those with ABSSSI (79.1% vs.
64.3%, P\ 0.001). Clindamycin was the second
most common antibiotic administered.
Although the use of clindamycin was higher in
patients with ABSSSI, this difference was not
statistically significant (27% vs. 18.9%,
P = 0.055). Cephalexin use was significantly
higher in patients with ABSSSI; however, the
overall use of this agent was low (6% vs. 0%,
P = 0.030).
A higher percentage of cases had an infec-
tious disease consult and were admitted to the
ICU (P\ 0.001). Length of stay was also signif-
icantly longer for cases (7.4 days vs. 2.7 days,
P\ 0.001). Secondary complications, clinical
failure at discharge, and re-infection within
30 days of discharge were more common in case
patients (P = 0.034, P = 0.003, P = 0.006,
respectively). Although in-hospital mortality
was low overall (2%), all deaths occurred among
case patients (P\0.001).
Table 2 displays the results of the multivari-
able logistic regression analysis. Variables asso-
ciated with ABSSSI ? BSI were male gender
(aOR 1.85, 95% CI 1.11, 3.66), acute renal fail-
ure (aOR 2.08, 95% CI 1.18, 3.67), intravenous
drug use (aOR 4.38, 95% CI 2.22, 8.62), prior
hospitalization (aOR of 2.41, 95% CI 1.24, 4.93),
abnormal temperature (aOR 2.86, 95% CI 1.66,
4.93), and elevated WBC (aOR 4.26, 95% CI
2.43, 7.47). Abscess or abscess and cellulitis were
protective against ABSSSI ? BSI (aOR of 0.220,
95% CI 0.11, 0.46 and aOR 0.139, 95% CI 0.07,
0.28, respectively). The Hosmer-Lemeshow
goodness of fit test was not significant
(P = 0.305), indicating that there was no evi-
dence of a lack of model fit.
A total of 166 patients (42.3%) met the cri-
teria for severe ABSSSI. Regarding risk factors for
severe ABSSSI, African American race (OR 2.17,
95% CI 1.43, 3.28), elevated WBC count (OR
2.32, 95% CI 1.52, 4.50), abscess and cellulitis
(OR 3.0, 95% CI 1.39, 3.17), recent antibiotic
exposure (OR 2.07 95% CI 1.02, 4.24), and prior
MRSA infection (OR 2.857 95% CI 1.05, 7.77)
were associated with severe ABSSSI on univari-
ate analysis.
Table 3 displays the results of the multivari-
able logistic regression analysis for severe
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Table 1 Demographics, sociodemographic, clinical characteristics, and outcomes of cases and controls, Detroit, MI,
2010–2015
Variables ABSSSI 1 BSI (n = 196) ABSSSI (n = 196) P value
Age (years), mean (SD) 52.4 (18.4) 45.3 (15.5) \ 0.001
Gender, n, (%) 0.008
Male 129 (65.8) 103 (52.6)
Female 67 (34) 93 (47.0)
Race, n, (%) 0.520
African-American 112 (57.1) 108 (55.1)
Asian 1(0.5) 1 (0.5)
Caucasian 68 (34.7) 78 (39.8)
Other 15 (7.7) 9 (4.6)
BMI[ 30 kg/m2, n, (%) 79 (41.6) 91 (46.4) 0.340
Sociodemographics, n, (%)
Education[ 30%\ high schoola 18 (9.2) 9 (9.6) 0.073
Median income\ povertyb 78 (39.8) 62 (31.6) 0.092
No medical insurance, n, (%) 39 (19.9) 36 (18.4) 0.399
Comorbid conditions
Chronic renal failure,n, (%) 25 (12.9) 8 (4.1) 0.002
Hepatic disease, n, (%) 18 (9.2) 4 (2.6) 0.005
Diabetes, n, (%) 76 (38.8) 49 (25.0) 0.003
Paraplegia, n, (%) 4 (2) 0 (0) 0.440
Hypertension, n, (%) 88 (44.9) 62 (31.6) 0.007
Congestive heart failure, n, (%) 19 (9.7) 7 (3.6) 0.015
IV drug abuse, n, (%) 44 (22.4) 25 (12.8) 0.012
Charlson Comorbidity Index, median, (IQR) 2 (1–5) 1 (0–3) \ 0.001
Prior hospitalization 180 days, n, (%) 63 (32.1) 25 (12.8) \ 0.001
Prior antibiotic use past 30 days, n (%) 18 (9.2) 16 (8.2) 0.720
Prior MSSA infection 60 days, n, (%) 6 (3.1) 0 (0) 0.014
Prior MRSA infection 60 days, n, (%) 11 (5.6) 7 (3.6) 0.334
History of ABSSSI past 60 days, n, (%) 22 (11.2) 14 (7.1) 0.162
Days from symptom onset to admission, median (IQR)c 5 (3, 7) 5 (2, 9) 0.358
Abnormal temperatured, n, (%) 87 (44.4) 38 (19.4) \ 0.001
Elevated WBCe, n, (%) 138 (60.3) 91 (39.7) \ 0.001
Acute renal failure, n (%) 98 (50) 48 (24.5) \ 0.001
Type of ABSSSI, n (%) \ 0.001
Abscess 56 (28.6) 74 (37.8)
Cellulitis 56 (28.6) 20 (10.2)
Abscess ? cellulitis 58 (29.6) 98 (50)
Infected wound 24 (12.2) 4 (2)
Ulcer 2 (1) 0 (0)
Infection site, n, (%) 0.930
Upper extremity 46 (23.5) 65 (33.2)
Lower extremity 84 (42.9) 83 (42.3)
Head/neck 31 (15.9) 20 (10.2)
Torso/trunk 35 (17.9) 28 (14.3)
Methicillin-resistant S. aureus, n, (%) 126 (64.3) 152 (77.7) 0.004
Polymicrobialf, n, (%) 21 (10.8) 22 (11.2) 0.886
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ABSSSI. African American race (aOR 2.18, 95%
CI 1.38, 3.4), elevated WBC (aOR 2.24, 95% CI
1.41, 3.55), and prior hospitalization (aOR,
2.07, 95% CI 1.19, 3.0) were independently
associated with severe infection. Although renal
failure and polymicrobial ABSSSI had an
increased association with severe infection (aOR
of 2.26, 95% CI 0.932, 5.5 and aOR of 1.87, 95%
CI 0.930, 3.74, respectively), these were not
statistically significant.
DISCUSSION
In this study, we examined a population in
urban Detroit, MI, at risk for ABSSSI and
ABSSSI ? BSI. Although risk factors have been
evaluated in patients hospitalized for ABSSSI,
there are limited studies on the risk for BSI in
patients with CO-ABSSSI [9]. In addition, there
are no investigations on the risk for BSI in
patients with ABSSSI from an urban environ-
ment such as Detroit. It is important to evaluate
inner-city populations because these popula-
tions often are of lower socioeconomic status
and therefore are at risk because of limited
access to appropriate medical care [26, 27].
These individuals may be more likely to delay
seeking medical attention, which increases the
risk of complications including hospitalization,
surgery, relapse, and readmission [8, 28]. A
delay in seeking medical attention for ABSSSI
can also lead to the acquisition of BSI with
severe complications including mortality
[11, 28].
Several researchers have examined the rela-
tionship between patient characteristics and BSI
in individuals with ABSSSI, which included the
acquisition of MRSA from the community, older
age, male gender, coronary heart disease, the
presence of infected prosthetic devices, health
care-associated infections, and abnormal WBC
and vital signs [6, 9]. However, these investiga-
tions included patients with hospital-acquired
infection, making it difficult to extrapolate
these findings to CO-ABSSSI ? BSI. In addition,
the contribution of socioeconomic factors was
not examined. Consistent with previous inves-
tigations, we have also found that older age,
male gender, abnormal temperature, and
Table 1 continued
Variables ABSSSI 1 BSI (n = 196) ABSSSI (n = 196) P value
Clinical outcomes
ID consult 115 (58.7) 54 (27.6) \ 0.001
Admission to ICU, n, (%) 25 (12.8) 5 (2.6) \ 0.001
Length of hospital stay (days), mean, (SD) 7.4 (5.7) 2.7 (2.2) \ 0.001
Clinical failure at dischargeg, n, (%) 22 (11.3) 7 (3.6) 0.003
In-hospital mortality, n (%) 8 (4.1) 0 (0) \ 0.001
Complications, n (%) 7 (3.6) 1 (0.5) 0.034
Surgery, n, (%) 106 (54.1) 118 (60.5) 0.199
I&D at bedside, n, (%) 37 (18.9) 88 (44.9) \ 0.001
I&D at OR, n (%) 68 (34.7) 76 (38.8) 0.402
Wound debridement at OR, n (%) 9 (4.6) 6 (3.1) 0.300
Re-infection within 30 days, n, (%) 22 (11.2) 8 (4.1) 0.006
ABSSSI acute bacterial skin and skin structure infection, BMI body mass index, BSI bloodstream infection, ICU intensive care unit, ID infectious disease,
I&D incision and drainage, IQR interquartile range, IV intravenous, n number, OR operating room, SD standard deviation, WBC white blood cell count
a [ 30%\High school education indicates patient resided in a zip code where[ 30% of the population of has not completed high school
b By zip code
c N = 207
d Temperature\ 35.6 C or[ 38.0 C
e WBC[ 11 9 109cells/l
f Skin/skin structure specimen
g Clinical failure at discharge defined as persistent symptoms, need for a change in antibiotics (not including antibiotic de-escalation) or further surgical
intervention
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elevated WBC on hospital admission were sig-
nificantly associated with ABSSSI ? BSI. Among
our study population, the presence of MRSA,
prior hospitalization, prior MSSA infection, and
[ 30% with less than a high school education
by zip code were additional risk factors.
Although income and other sociodemographic
characteristics had been previously evaluated
for MRSA infections, the relationship between
education level and ABSSSI ? BSI had not been
reported previously.
In the present study, a number of comorbid
conditions were also found to be associated
with ABSSSI ? BSI including acute and chronic
renal failure, hepatic disease, diabetes, hyper-
tension, congestive heart failure, and intra-
venous drug abuse. Several of these factors had
been previously reported. However, these stud-
ies focused only on hospitalized patients;
therefore, the data may not be generalizable to
patients who derived BSI in the community [9].
Abscess or abscess plus cellulitis appeared to
have a protective effect against BSI. The most
probable explanation for this finding may be
related to routine medical intervention that
commonly includes incision and drainage of
the abscess, which removes the focus of the
infection and therefore probably protects the
patients from BSI as a complication of ABSSSI
[1, 10, 29].
As expected, a significantly higher percent-
age of patients with ABSSSI ? BSI required an
infectious disease consult, were admitted to the
ICU, deemed a failure at time of discharge, and
had a higher rate of mortality and reinfection
within 30 days of discharge underscoring the
need for early detection and optimized man-
agement in patients with ABSSSI ? BSI.
As pertains to our second research question
examining risk factors for severe ABSSSI defined
as need for surgical intervention in the operat-
ing room, amputation, ICU admission, or severe
sepsis, we found that African American race,
elevated WBC on admission, prior hospitaliza-
tion, and presence of abscess plus cellulitis were
independently associated with severe infection.
Other researchers have found that African
Americans have significantly higher rates of
skin and soft tissue infections compared with
Caucasians [8]. In addition, African Americans
Fig. 1 Comparison of antibiotic treatment for cases vs.
controls, Detroit, MI, 2010–2015. ABSSSI acute bacterial
skin and skin structure infection, BSI blood stream
infection, AMOX/CLAV amoxicillin-clavulanate, AMP/




of low socioeconomic status have previously
been found to have a higher rate of persistent
infection, higher readmission rates, and
increased infection complications [13, 28, 30].
However, the impact of race on severity of dis-
ease in patients with ABSSSI and ABSSSI ? BSI
had not been evaluated prior to the present
study.
Patients in our study diagnosed with celluli-
tis without abscess had a significantly lower OR
for severe disease while abscess plus cellulitis
was associated with an increased risk of severe
disease. Individuals with abscess are more likely
to have surgical drainage as a part of their
treatment intervention, which removes the foci
of infection and improves the likelihood of
antibiotic success [1, 10, 29]. This procedure
likely prevents patients’ localized infection
(abscess) from spreading into the surrounding
tissue causing cellulitis and potentially BSI.
Individuals with abscess plus cellulitis already
have an extensive infection that has spread into
the surrounding tissues, which may explain the
observed association with severe infection.
However, the fact the foci could still potentially
be removed may at the same time explain the
protective effect against BSI.
Study Limitations
This study had a retrospective study design and
therefore was subject to all of the potential
biases associated with this type of investigation.
For example, it was possible that there were
missing data or incomplete data recorded in the
EMR. While it appeared that incomplete or
missing data were minimal during the data
collection, it is possible that some data were not
recorded or were recorded incorrectly. Another
potential limitation was the assumption that in
patients with the diagnosis of cellulitis and BSI,
the S. aureus identified in the bloodstream
originated from the patient’s cellulitis. Cellulitis
is a deep-seated infection of the subcutaneous
tissues of the skin, and therefore it is difficult to
culture the pathogen causing disease. While S.
aureus is a pathogen associated with cellulitis,
Table 2 Logistic regression analysis of patient risk factors for ABSSSI ? BSI
Factor Unadjusted OR 95% confidence interval Adjusted OR 95% confidence interval
Gender (male) 1.74 1.16, 2.61 1.85 1.11, 3.66
[30%\High school educationa 2.10 0.92, 4.80 2.91 0.98, 8.64
Acute renal failure 3.08 2.0, 4.74 2.08 1.18, 3.66
IV Drug abuse 1.98 1.16, 3.39 4.38 2.22, 8.62
Charlson Comorbidity Index 1.29 1.18, 1.42 1.13 0.99, 1.28
Hospitalization within 180 days 3.24 1.93, 5.43 2.41 1.24, 4.70
Abnormal temperatureb 3.25 2.07 2.86 1.66, 4.93
Elevated WBCc 2.75 1.81, 4.16 4.26 2.43, 7.47
Abscess 0.659 0.432, 1.01 0.220 0.11, 0.46
Abscess ? cellulitis 0.420 0.28, 0.64 0.139 0.07, 0.28
Hosmer-Lemeshow p = 0.305
ABSSSI: acute bacterial skin and skin structure infection; BSI: bloodstream infection; IV: intravenous; OR: odds ratio;
WBC: white blood cell count
a [ 30%\High school education indicates patient resided in a zip code where[ 30% of population of has not completed
high school
b Temperature\ 35.6 C or[ 38.0 C
c WBC[ 11 9 109cells/l
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other bacterial pathogens such as streptococci
are also a frequent cause of cellulitis [2, 10].
Therefore, although unlikely, cases of BSI where
cellulitis without abscess was identified as the
infection type may have been misclassified.
Additionally, we evaluated the impact of race
and ethnicity on severity of disease. The com-
posite definition for severity included amputa-
tion. However, no amputations were recorded
in the population cohort. It was possible that
the exclusion of diabetic foot infections from
this study is the most likely reason for the lack
of amputations because surgical intervention
including amputation is common among this
population. Further, one of the objectives of
this investigation was to determine whether
sociodemographic characteristics were associ-
ated with ABSSSI ? BSI. However, this infor-
mation was derived by zip code that was
provided through Federal census data. Infor-
mation on education and level of income was
not available on an individual basis; therefore,
the information was limited. We observed that
patient outcomes were poorer among those
with bacteremia. We did not further investigate
the impact of treatment factors, such as drug
choice or time to effective therapy, because it
was beyond the scope of our research objective;
however, future studies investigating the
impact of management strategies on outcomes
specifically in ABSSI ?BSI would be valuable.
Unfortunately, the time from symptom onset to
presentation was not consistently documented,
and therefore we were unable to analyze this
factor. Lastly, the study was conducted on a
population of mostly African American indi-
viduals who resided in Detroit or its immediate
surrounding areas. Therefore, it is possible that
the results of this investigation cannot be
extrapolated to other metropolitan
populations.
CONCLUSION
We have identified a number of patient char-
acteristics, including sociodemographic factors
such as level of education, that may contribute
to BSI in patients with ABSSSI. In addition,
several factors including African American race
were associated with a higher degree of infec-
tion severity. According to these findings, there
is a need to include sociodemographic charac-
teristics when evaluating infection-related
patient outcomes. Partnerships among com-
munity organizations, public health authorities,
and intercity hospitals are needed to educate,
screen, and identify individuals at risk to pre-
vent these infections in this patient population.
Further research is warranted to more fully
characterize these risks and prevent these com-
plications in this vulnerable patient population.
Table 3 Logistic regression analysis of patient risk factors by severity
Factor Unadjusted OR 95% confidence interval Adjusted OR 95% confidence interval
African American 2.17 1.43, 3.28 2.18 1.38, 3.44
Elevated WBCa 2.32 1.52, 4.5 2.24 1.41, 3.55
Acute renal failure 1.50 0.73, 3.06 2.26 0.932, 5.49
Cellulitis 0.155 0.087, 0.31 0.202 0.92, 0.44
Abscess ? cellulitis 3.0 1.39, 3.17 1.65 1.03, 2.65
Polymicrobialb 1.84 0.97, 3.49 1.86 0.930, 3.74
Hospitalization within 180 days 1.58 0.98, 2.56 2.07 1.193, 3.59
Hosmer-Lemeshow p = 0.843
OR odds ratio, WBC white blood cell count
a WBC[ 11 9 109cells/l
b Skin/skin structure specimen
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